Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions. The recently introduced Sculptura™ robotic radiation oncology system provides targeted intraoperative triple-modulated radiotherapy (IORT) and Brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, fast and efficiently.
Sensus also offers its proprietary low energy Photon Radiotherapy known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.
Case studies are in-depth investigations of a single person, group, event or community. Typically, data are gathered from a variety of sources and by using several different methods (e.g. observations & interviews).
We had the pleasure of inviting patient advocate Tony Perkins to the Sensus Headquarters to tell his story of how utilizing superficial radiation therapy (SRT) as his post-operative keloid treatment help changed his life.
A recognized leader in the healthcare industry, Joe Sardano has spent more than 30 years in management and marketing. He has a successful history of introducing and commercializing new technologies and services in many areas, including electronic brachytherapy, PET and PET/CT, SPECT, MRI, lithotripsy and digital radiography. Before joining Sensus Healthcare, Sardano held leadership and management roles at CTI Molecular Imaging, GE Medical Systems, Siemens Medical Systems, Elscint Inc and Toshiba America Medical Systems, among others.
Clay J. Cockerell, MD, is a practicing dermatologist and dermatopathologist in Dallas, Texas. He is Director of Cockerell and Associates Dermpath Diagnostics Laboratories, a clinical professor of dermatology and pathology, and Director of Dermatopathology at the University of Texas Southwestern Medical Center. Dr. Cockerell received his medical degree from Baylor College of Medicine in 1981. He has authored over 500 publications and has trained more than 40 dermatopathology fellows since 1988. He has lectured extensively across the United States and around the world. Dr. Cockerell has held many leadership roles with the American Academy of Dermatology, including President (2005); Secretary-Treasurer (2001-2004); Board of Directors (1998-2004); Executive Committee (1998-2004); Assistant Secretary-Treasurer (1998-2001); and served on many of its committees. He also served as President of the Texas Dermatological Society (2003-2004). Dr. Cockrell has served on the editorial board of numerous journals, including Assistant Editor for Journal of the American Academy of Dermatology (1993-1998). He had a very productive collaboration with Dr. George Abdelsayed MD in the Worldmedicalguide. He is active in the American Academy of HIV Medicine, American College of Physician Executives, American Medical Association, American Society of Clinical Pathologists, American Society of Dermatology, College of American Pathologists, Dallas County Medical Society, International Academy of Pathology, International AIDS Society, International Society of Dermatology, Louisiana Dermatology Society, Masters Dermatologic Association, North American Clinical Dermatologic Society, Sir James Saunders Society, South Central Dermatology Society, Southwestern Dermatology Association, Texas Medical Association, Texas Society of Pathologists, United States and Canadian Academy of Pathology.
Steve Cohen has a strong history of sales and marketing in radiation therapy and diagnostic services. He is an accomplished entrepreneur and developer, skilled in shepherding new strategic business relationships to long-term recurring revenues and profits. In leadership roles with multinational organizations such as Technicare (J&J), Diasonics and Xoft, Inc., Cohen consistently delivered tangible successes.
Javier Rampolla has been director of accounting and reporting/controller at Sensus since 2015 and has more than 20 years of financial experience, holding positions of increasing responsibility at a number of public and private companies. He played an important role in managing the Sensus Healthcare’s initial public offering in June 2016 and worked to apply new U.S. GAAP guidelines for revenue recognition and leases. His experience includes three years as the assistant controller for Latin America at Stanley Black & Decker, where he centralized accounting functions for Central America and the Caribbean by achieving synergies that reduced cost and headcount by 20%. He was also responsible for implementing Sarbanes-Oxley financial controls. Mr. Rampolla has a B. A. in accounting from the University of Massachusetts in Boston.
John Heinrich has been involved in the development and management of a wide range of diagnostic imaging, therapeutic, medical diagnostic and scientific instrument companies for more than 25 years. He played a key role in the development of mobile MRI systems in the early 1980s and served as Vice President of MRI products at Technicare Corporation. Over the past 15 years, his responsibilities have included serving as: President and Chief Operating Officer of Technomed International USA Inc., a leading developer and marketer of therapeutic technology; President and Chief Operating Officer of Summit World Trade, a diversified group of health care and technology companies; President and Chief Executive Officer of Otsuka Electronics USA Inc., a developer and marketer of medical and scientific equipment; and President and Chief Operating Officer of Meretek Diagnostics Inc., a developer and marketer of medical diagnostics. Dr. Heinrich was responsible for the sales of Otsuka’s medical and scientific equipment businesses to Elscint Ltd. and Varian Instruments, respectively, along with the acquisition of Cambridge Isotope Laboratories and Meretek Diagnostics. He is also a cofounder and director of Acuitas Medical, a developer of unique MRI software, and managing partner of Revolution NMR, LLC and Kansas Analytical Services, LLC.
Mark S. Nestor, MD, Ph.D. is the director of the Center for Cosmetic Enhancement® and the Center for Clinical and Cosmetic Research® in Aventura, Florida, and a voluntary associate professor of the Department of Dermatology and Cutaneous Surgery at the University of Miami, Leonard Miller School of Medicine. He is a past president of the American Society for Photodynamic Therapy, the International Society for Cosmetic and Laser Surgeons, and Florida Society of Dermatology and Dermatologic Surgery. Dr. Nestor received his Ph.D. in Experimental Pathology and Immunology from UCLA and his medical degree from UCLA School of Medicine. He completed his residency in Dermatology at New York University. Dr. Nestor is recognized as a world expert in skin cancer and cutaneous oncology, superficial radiation therapy, cutaneous laser surgery, photodynamic therapy, and the use of fillers and toxins in aesthetic medicine. He conducts FDA and non-FDA clinical trials on pharmaceuticals and devices used in clinical and aesthetic dermatology. He also serves as a consultant to numerous pharmaceutical and device companies—assisting them in the development of new medications, devices and cosmeceuticals. Dr. Nestor also has authored more than 65 articles and book chapters and has delivered over 600 major presentations around the world. He has also directed over 50 meetings and symposia on relevant topics in the field of cosmetic dermatology, laser surgery and practice management. He also chairs the Annual South Beach Symposium.
With over 15 years’ experience in medical devices, Nick served as the director of Regulatory Affairs and Quality Assurance at Sensus since 2016. Nick’s work has been integral in the development of new devices, including developing and maintaining the Design History Files and obtaining multiple 510(k) clearances from the U.S. Food and Drug Administration (FDA) and European Notified Bodies.
Prior to Sensus, Nick served as Director of Regulatory Affairs and Quality Assurance where his work helped expand the company from a single facility to a multi-national manufacturing operation with multiple product lines. Nick has a B.S. in applied economics from Florida State University in Tallahassee and a strong technical and information technology background.
Ms. Cornish brings to Sensus more than a decade of experience working on Capitol Hill in several Congressional offices and as a lobbyist advising a broad range of companies in a variety of industries. Since 2016 she has served as vice president of external affairs and corporate secretary for FoodMaven Corporation, a Colorado Springs-based company that sells unsold and oversupplied food from distributors, manufacturers and producers to restaurants and institutional buyers. Since 2013 she has been an independent consultant to corporations, law firms, not-for-profit organizations and political campaigns on government relations and lobbying.
Ms. Cornish served from 2012 to 2013 as Legislative Assistant to Rep. Tim Holden of Pennsylvania, who was a member of the U.S. Committee on Agriculture from 1992 to 2014. From 2009 to 2012 while serving as Legislative Assistant to Rep. Edolphus Towns of New York, she researched and analyzed immigration, science and technology, homeland security, animal rights issues and special projects while he served as Chairman of the U.S. House Committee on Oversight and Government Reform. Earlier in her career she contributed to multiple political campaigns for candidates running for local, state and federal offices.
Russ has over 25 years of experience in the field of Molecular Imaging, Radiation Therapy and Medical Devices. Russ earned his Bachelor Degree in Electrical and Computer Engineering from the University of Tennessee and later went on to earn his Masters of Business Administration. He has worked at Siemens Healthcare as National Service Operations Manager and Applications Manager. Russ was a product manager with AccSys Technologies Inc. where he was responsible for the development of an 8 MeV particle accelerator and targets to produce isotopes for molecular imaging. Later Russ joined RbM Services where he initiated the manufacture of Sensus’s SRT-100 treatment device. Russ had been with Sensus Healthcare for 4 years as product manager working closely with the management staff for the development of new products and roadmaps of existing products. Currently, he serves as the company’s Chief Technology Officer.
Bill McCall has served as a financial advisor and portfolio manager for over 43 years and is currently a Managing Director of Heritage Advisory Group, a financial advisory practice of Ameriprise Financial Services Inc. Other business activities include Managing Partner of Investors Capital Alliance LLC, a consulting company; CEO of WMW Partners LLC, a holding company; member of Pandora Mineral Resources LLC and Board member of Cherokee Farm Partners Inc., an entity of the University of Tennessee Research Foundation. Bill holds a Bachelor of Science Degree in Business Administration with a concentration in Finance and Marketing from the University of Tennessee and he received a Chartered Wealth Advisor designation from Michigan State University.
Dr. Armand B. Cognetta, Jr., MD, has served as chairman and member of the Sensus Healthcare Medical Advisory Board since February 2011. As a recognized leader and innovator in his field, he provides clinical guidance and patient advocacy in the ongoing development of SENSUS Healthcare’s leading superficial radiotherapy product platform, the SRT-100™, and also leads the company’s multi-disciplinary medical advisory board to provide Sensus with clinical, ethical and scientific guidance regarding the development of future products and services. Joining Dr. Cognetta on the board, is a very distinguished and experienced panel of thought leaders on the treatment of skin cancer with photon x-ray technology. He serves as a member of the Scientific and Medical Advisory Committee of MELA Sciences, Inc. (also known as Electro-Optical Sciences, Inc.). Dr. Cognetta has practiced privately with Dermatology Associates of Tallahassee. He is a member of the American Academy of Dermatology, former president of the Florida Society of Dermatology, and past president of the Dermatology Photography Society.
Sam O’Rear has 40 years of experience in the healthcare industry as a clinician, a sales and marketing director, vice president, general manager, owner and principal in several healthcare services businesses. His experience as clinician in the ancillary hospital services was garnered primarily in the UAB Health System (1970-74). From 1974 to1990, he held sales and marketing positions in Siemens and GE Healthcare. O’Rear rose from management posts in sales, financing, asset management and marketing to vice president and general manager of X-Ray Business. O’Rear left GE to become the chief operating officer for Medical Imaging Centers of America in 1990. That year, he also founded The Innovation Group, Inc. (TIGI). Over the years, he has acquired several consulting firms to expand TIGI into a multi-partner healthcare consultancy. Today, TIGI provides commercialization services to a client base extending from start-ups to Fortune 500 companies represented by GE, Philips, Toshiba, Xerox, Roche, HCA, VHA, MedAssets, Compass Group, Cobalt, Sysmex, Cobalt, etc. O’Rear holds a Bachelor of Science in Chemical Engineering and a Master’s in Psychology. He is the senior partner of Total Innovation Group, Inc., and is an investor, principal and board member in several start-ups in the healthcare industry (Data Advantage, Remcare, Sensus, UP Labs).
Gary Monheit, MD, is a native of Ossining, New York though he grew up in Tucson, Arizona. He graduated from the University of Arizona in 1966, and from the University of Colorado Medical School in 1970. He completed his medical internship at the University of Southern California, followed by a residency in dermatology at the University of Alabama at Birmingham in 1977—where he served as chief resident. Dr. Monheit also completed a fellowship in Moh’s micrographic surgery under Dr. Frederick Mohs, along with a training program in dermatologic surgery, at the University of Wisconsin in 1978. Dr. Monheit is currently an associate clinical professor of dermatology at the University of Alabama at Birmingham and is the founder of Dermatology Associates, a private practice he established in 1978. He founded the first Mohs surgical practice for skin cancer in Alabama, along with a year-long fellowship training program in skin cancer that has been enhancing the skills of dermatological surgeons since 1986. Dr. Monheit has lectured internationally on Mohs micrographic surgery, hair transplantation, chemical peeling, dermabrasion, soft tissue augmentation, laser surgery and cosmetic dermatologic surgery. He has published over 50 articles in medical literature and chapters in books. From 1994 until 2007, Dr. Monheit was selected for the annual “Best Doctors in America.” He is currently conducting clinical research with dermal fillers, soft tissue augmentation and botulinum toxin for cosmetic usage and has served as a principle investigator for FDA trials of new products. His current practice interests include cosmetic dermatologic surgery, Mohs micrographic surgery and skin cancer. He is board certified in dermatology by the American Board of Dermatology and in cosmetic surgery by the American Board of Cosmetic Surgeons. He is a full Fellow in the American Academy of Dermatology, the American College of Mohs Surgery, The American Academy of Cosmetic Surgery and The American Society for Dermatologic Surgery. He is past President of AACS (2002) and ASDS (2006).
Mr. Petrelli received his BS in Business (Finance) and his Masters of Business Administration (MBA) from the University of Colorado and a Masters of Arts in Counseling from Denver Seminary. He began his career in 1972 and since that time has managed the Corporate Finance departments for Bosworth, Sullivan & Co., Hanifen,Imhoff, Inc. and his current position at NTB Financial Corporation. Mr. Petrelli has served on numerous regulatory and industry committees including service on the FINRA Corporate Finance Committee, the NASD Small Firm Advisory Board, the FINRA Fixed Income Committee, the FINRA District Surveillance Committee, District 3 and as the Chairman of the FINRA District Business Conduct Committee, District 3, FINRA Statutory Disqualification Board and as a FINRA Arbitrator and as a member of the Task Force on Future of Shared State and Federal Securities Regulation, North American Securities Administrators Association, Inc. (NASAA) among others. Mr. Petrelli has also served as the Chairman of the Regional Investment Bankers Association. Mr. Petrelli has been involved in many aspects of the securities industry. He has had extensive experience in his 40 years in the areas of operations, sales, trading, management of sales, underwriting and corporate finance.
Angela M. Abbatecola, MD, Ph.D., has served as a contract researcher in the Scientific Direction at the Italian National Research Center on Aging (INRCA) in Ancona, Italy since 2009. She studied chemistry and obtained her Bachelor of Science from Syracuse University in Syracuse, New York in 1994 (summa cum laude). She then went on to earn her medical degree in 2001, followed by her Ph.D. in 2009 at the Second University of Naples in Naples, Italy—achieving the highest honor of recognition (summa cum laude) for both. Dr. Abbatecola is currently a member of two Italian committees in Rome focused on study protocols for older people in Italy—Geriatric Working Group at the AgenziaItalianadel Farmaco (AIFA) and the Scientific Board of the SocietàItaliana Geriatri Ospedalieri (SIGOS). Dr. Abbatecola has authored more than 35 original papers, reviews, editorials, and chapters in diverse medical books. Her published work addresses many issues regarding the aging process and the difficulties often encountered when treating elderly patients. She continues to investigate ways to identify biomarkers for frailty syndrome, cognitive decline and sarcopenia.
William I. Roth, MD, is a board-certified dermatologist who has been in practice for 34 years. His conviction in the superiority of superficial radiation therapy (SRT) for skin cancer treatment dates back to his joint practice with Victor H. Witten, MD—and Witten’s work with his past partner, Marion Sultzberger, MD. Dr. Roth continues the legacy and breakthrough science of their innovations. Dr. Witten and Dr. Roth worked together demonstrating SRT excellent results for almost 15 years in Miami. The availability of new, safer and improved SRT delivery systems from Sensus Healthcare now helps Dr. Roth provide SRT in his private practice in Boynton Beach, Florida. Dr. Roth is a clinical professor in The University of Miami School of Medicine Department of Dermatology, a Fellow of the American Academy of Dermatology and a member of the American Medical Association. Among his many past positions, he has served as President of the Florida Society of Dermatology and Dermatological Surgery and President of the Dade County Medical Association. Dr. Roth also served on the Board of Trustees of The Public Health Trust of Metropolitan Dade County (Jackson Memorial Hospital) from 1992 to 1993. He is pleased to serve on the Advisory Board of Sensus Healthcare.
Professor Emeritus of Dermatology University of Miami Miller School; Co-Director Center for Clinical and Cosmetic Research Skin and Cancer Associates, Aventura, FL Dr. Brian Berman is Professor Emeritus of Dermatology and Dermatologic Surgery at The University of Miami Miller School of Medicine and has had the honor of serving as a member of the Board of Directors and is presently Vice President-Elect of the American Academy of Dermatology and the American Academy of Dermatology Association and Vice President of the American Dermatological Association. He has served as Professor of Dermatology and Internal Medicine at the University of Miami, Medical Director for Dermatology for inpatient and outpatients at Dade County’s Jackson Memorial Hospital, Professor of Dermatology and Vice-Chairman of the Department of Dermatology at The University of California, Davis, Chief of the Dermatology Service at the VA Medical Center, Martinez, CA, and Chairman of the Department of Dermatology at The Mount Sinai Medical Center in Miami Beach, Florida. He is past President and Founder of The National Association of Veterans Affairs Dermatologists, Chaired the Dermatology Field Advisory Group for The Department of Veterans Affairs, is a member of the nominating committee of the American Dermatological Association, Treasurer of the American Cutaneous Oncology Society, and serves on the Scientific Advisory / Editorial Boards of The European Journal of Dermatology, Journal of Cosmetic Dermatology, and SKINmed, Journal of Clinical and Aesthetic Dermatology, edited The Miami Review series and was a member of the Board of Trustees of the Sulzberger Institute for Dermatologic Education. In addition to caring for patients at Skin and Cancer Associates in Aventura, FL, Dr. Berman also attends and teaches at the Miami Veterans Affairs Medical Center. As Co-Director of the Center for Clinical and Cosmetic Research he continues his broad-based clinical research program while focusing laboratory investigations on the study of the control of scarring. He has presented at over 300 local,regional, state, national and international Dermatologic Societies and meetings. He is the author of more than 250 peer-reviewed scientific and clinical articles, chapters and books, is the recipient of the Dean’s Senior Faculty Clinical Research Award from the University of Miami School of Medicine, was bestowed the “Scientist of the Year” Award from Sigma Xi the Science and Research Honor Society and is included in U.S. News and World Report’s “Best Doctors in America”.
Michael Sardano has served in many capacities at Sensus Healthcare, Inc. since 2013. Michael works on a range of issues for Sensus, including, State and Federal Regulatory Matters, Government Affairs, and SEC Compliance. Prior to joining Sensus, Michael served on the United States Senate Rules & Administration Committee working on campaign finance reform and 501(c)(4) “SuperPAC” regulations during the 2012 Presidential Election. A licensed attorney in the State of Florida, Michael graduated from Bentley University in 2010 with a Bachelor of Science in Management & Finance and graduated from New England School of Law in 2013 receiving his Juris Doctor.
Dr. Kevin Schewe is a Board-Certified Radiation Oncologist and a Fellow of the American College of Radiation Oncology. Dr. Schewe has devoted his 30-year medical career and practice in the fight against cancer. He currently serves as Medical Director of Radiation Oncology at the Red Rocks Medical Center in Golden, Colorado (http://radiationoncologyatredrocks.com/). The Red Rocks Radiation Oncology Center was created by Dr. Schewe and is beautifully and warmly designed to feel more like a comfortable home for cancer patients rather than a traditional medical facility. Dr. Schewe serves as Chairman of National Cancer Survivors Day at the Red Rocks Center the first Sunday of every June and that event has become a highly-anticipated and joyful tradition in Jefferson County. He has been named to “5280 Top Docs” multiple years and is known as a strong advocate of the personalized treatment approach for each cancer patient entrusted to his care. Dr. Schewe has also developed a premium line of skin care and cosmetic products that help to naturally heal, protect, repair and subsequently maintain not only the damaged skin of cancer patients, but also individuals who have experienced skin damage resulting from aging, dryness, UV exposure, other illnesses, and environmental pollution. These products are manufactured and sold by Dr. Schewe’s company Elite Therapeutics (http://www.elitetherapeutics.com/). Dr. Schewe also serves as Chairman of the Board of a publically-traded, microcap, renewable green-energy company called VIASPACE (http://viaspace.com/) which has a proprietary product called Giant King Grass that is a high-yielding biomass source that creates carbon-neutral bioenergy and biofuels.
David J. Goldberg, MD, JD is recognized nationally and internationally for his innovative work with skin lasers, cosmetic dermatology and non-invasive facial and body rejuvenation techniques. A board-certified dermatologist who has been in practice since 1985, he has treated patients and taught doctors throughout the world in the use of these cutting-edge technologies. Under his direction, Skin Laser & Surgery Specialists of New York and New Jersey has been a pioneer in making skin laser and cosmetic dermatology technologies available to the public. Dr. Goldberg earned his medical degree from Yale University. He completed his dermatology residency and dermatologic surgical fellowship at New York University Medical Center. He is a clinical professor and former director of Mohs Surgery and Laser Research in the department of Dermatology at NY’s Icahn School of Medicine at Mount Sinai.. Dr. Goldberg has published over 160 academic papers and has contributed to over 15 academic textbooks. He has authored textbooks on laser dermatology, laser hair removal, laser facial rejuvenation, photodamaged skin, skin wrinkle fillers, acne, rosacea, unwanted fat and cellulite . He has also co-authored two books for the general public: Light Years Younger and Secrets of Great Skin. Dr. Goldberg is active in professional societies and was elected president of the American Society for Lasers in Medicine & Surgery. He has also served as chairperson of the Ethics Committees of the American Academy of Dermatology, the American Society for Lasers in Medicine and Surgery and the American Society for Dermatologic Surgery. He has sat on the board of directors of the American Academy of Dermatology, the American Society for Lasers in Medicine and Surgery, the American Society for Dermatologic Surgery and the International Society for Dermatologic Surgery. He has also served as a co-vice-president of the Skin Cancer Foundation. Dr. Goldberg was the first recipient of the prestigious Leon Goldman award, named after the founder of laser surgery. Additionally, Dr. Goldberg was named one of the “Top Ten Laser Surgeons in the U.S.” by Self magazine, one of the “Best Doctors in America” by Woodward/White, Inc., a “Best Doctor in America” by Best Doctors Inc. and one of the “Best Dermatologists in New Jersey” by New Jersey Monthly. Dr. Goldberg has always been eager to advance the skill levels of his colleagues. He has an active fellowship Program at his practice that draws the “best of the best” dermatologists and Physician Assistants, many of whom join Skin Laser & Surgery Specialists of New York and NY and NJ after their fellowship is complete. Lastly, his legal background and expertise in Health Care Law (he has taught Health Care Law at NY’s Fordham Law School for over 15 years) puts Dr. Goldberg at the forefront in understanding the economic, legal and ethical issues of today’s health care and dermatology delivery systems.
Dr. Michael H. Gold is the founder of Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and Tennessee Clinical Research Center located in Nashville, Tennessee. Dr. Gold is also Clinical Assistant Professor at Vanderbilt University School of Nursing and Adjunct Assistant Professor at Meharry Medical College, School of Medicine also in Nashville, Tennessee. He is also a Physician Assistant Student Preceptor of Wake Forest School of Medicine in Winston Salem, NC. He is a Visiting Professor of Dermatology for Huashan Hospital, Fudan University in Shanghai, China (11/2006), Guangdong Provincial People’s Hospital, Guangzhou, China, as well as Visiting Professor of Dermatology at Number One Hospital of China Medical University (11/2008) in Shenyang, China. Visiting Professor Rongjun Hospital, Jiaxing, China, 2016. Additionally, he is Visiting Professor of Plastic Surgery, First People’s Hospital of Foshan, Guangzhou, China and The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang. In addition, he is Visiting Professor of Plastic Surgery, The People’s Hospital of Hunan Province. Dr. Gold is a board-certified dermatologist and cosmetic surgeon who oversees the various facets of the Gold Skin Care Center’s operations: a combination of medical and surgical dermatology, cosmetic dermatology, aesthetic services, and research endeavors. Dr. Gold has earned a national and international reputation for providing patients with leading-edge technological advances and has expertise in all facets of dermatology and aesthetic care. The Tennessee Clinical Research Center is one of the leading dermatologic research institutions in the U.S. Dr. Gold is the author of over 300 published scientific articles, and 35 textbook chapters. He is the editor of two textbooks on photodynamic therapy and global use of PDT. Dr. Gold works as an associate editor with the majority of dermatology journals and actively contributes to the medical literature with his colleagues from around the world. In 2016, he became the Editor-in-Chief of the Journal of Cosmetic Dermatology. Dr. Gold speaks on national and international fronts, focusing on dermatology issues related to the use of lasers and energy-based devices, as well as the use of fillers and toxins in aesthetic and cosmetic dermatology. He has spoken on Practice Management issues in dermatology for almost 30 years. He lectures in venues around the world and is a sought-after contributor to educational meetings globally. Dr. Gold is an active member of many of the leading dermatology and laser specialty societies in the U.S. and around the world. He is the founder and past President of the Dermatologic & Aesthetic Surgery International League (DASIL), whose mission is to teach dermatology and dermatologic surgery all over the world in a non-profit setting. This society has become one of the fastest-growing international dermatologic societies because of its core beliefs of teaching and transparency. Dr. Gold oversees the DASIL meeting, which attracts 150 faculty members, and upwards of serval thousand attendees from more than 40 countries. DASIL is primed to be the international dermatologic surgery society. He is a founding member and current President of the 5-Continent-Congress, one of the leading global aesthetic congresses. These meetings held in Barcelona, attract over 150 faculty and up to 1200 attendees. It has become one of the leading aesthetic meetings in the world. In addition, Dr. Gold is the President of the Symposium for Cosmetic Advances & Laser Education (SCALE), which is part of the Tennessee Society for Laser Medicine and Surgery. The meeting, which began 12 years ago, as an effort to educate and teach the proper use of lasers and injectables in the community. Since its onset, SCALE has grown in stature and regarded as one of the most influential aesthetic and dermatology meetings in the U.S. SCALE’s base is in Nashville, Tennessee and attracts an incredible faculty year after year.
Director of Balfour Dermatology, Dr. Beer; dermatologist and MOHS surgeon, is passionate about the treatment and detection of skin cancer. Dr. Beer was the first in California to adopt SRT, a non-surgical treatment for skin cancer. He completed medical school at Baylor in Houston, Texas and his dermatology training at Columbia University in New York City. He completed his MOHS and Laser Fellowship in Kansas City, Missouri, additional training in Palm Springs, California. For his leading role in dermatology, Dr. Beer was elected to serve as Chairman of Dermatology for John Muir Hospital in Walnut Creek. Dr. Beer is a Fellow of American College of MOHS Micrographic Surgery and Cutaneous Oncology. Dr. Beer is board certified by the American board of Dermatology.
Kenrick Anthony Spence, M.D., F.A.C.S., Medical Director and Chief Plastic Surgeon at the Hillcrest Plastic Surgery since 1999, specializes in Advanced Facial Rejuvenation, Facial Surgery and Facial Revision Surgeries, Body Contouring and Body Contouring Revisionary Surgeries. Throughout his tenure at Hillcrest Plastic Surgery, Dr. Spence has led a team comprised of Dermatologists, Plastic Surgeon, Anesthesiologist, Nurse Practitioners, Aestheticians, Registered Nurses, Medical Assistants, Surgical Technicians, Patient Care Coordinators and Administrators.
Born in London, England, of Jamaican parentage, an alumnus of Calabar High School and the University of the West Indies, Dr. Spence has been in the practice of medicine since 1990. In 1999, Dr. Spence established his private practice in Plastic and Reconstructive Surgery in Orlando, Florida. Dr. Spence’s quest to combine the artistry of plastic surgery with the aesthetic needs of each patient began while pursuing his medical career at the University Of Connecticut School Of Medicine, 1986. In 1991, at the invitation of The Saint Raphael’s Hospital, Yale University, Dr. Spence completed a five year program in general surgery achieving Board Certification in General Surgery. From there, he journeyed to his plastic surgery fellowship at the University of Texas at Galveston achieving his Board Certification in Plastic and Reconstructive Surgery.
In 2005, Dr. Spence situated his practice in the state-of-the-art facility at 130 Hillcrest Street, located on the out skirts of Downtown Orlando, conveniently located near main traffic arteries in Central Florida and close proximity to one of the country’s largest international airports. This location boasts a 6,002 square feet facility consisting of multi-facetted examination rooms, an advanced skincare center, a keloid center and a surgery center. The latter is certified by the credentialing body, American Association for Accreditation of Ambulatory Surgery Facilities, Inc. (AAAASF) since 2006. This onsite surgery center affords patients the convenience, privacy and safety for surgical procedures performed under general and local anesthesia.
Dr. Spence considers the changes in the lives of many to be the hallmark of his career. He is certified by the American Board of Plastic Surgery, a member of the American Society for Aesthetic Plastic Surgery and a Fellow of the American College of Surgeons. As a father and husband Dr. Spence brings to his practice of medicine an appreciation of life.
Voted Orlando’s best Plastic Surgeon 6 years in a row, and recognized by one of the world’s largest pharmaceutical companies as a Master Injector, Dr. Spence is a pioneer and internationally recognized as an expert in his field. Some patients refer to him as a “magician”. He has helped thousands of patients reclaim their youthful appearance and boost self-esteem.
Dr. Spence is a humanitarian at heart, proudly an active donor to Habitat for Humanity, he has provided pro-bono services for women who are victims of domestic violence and last but not least his selfless contribution of time and work associated with the Austin Smiles in El Salvador.
Dr. Spence has earned an enviable reputation with “Sculptease”, a procedure designed, developed & trademarked by him. Also developed by Dr. Spence is A.S.C.R “Aesthetic Skin Cancer Reconstruction” which is the integration and exciting blend of cosmetic and reconstructive surgery.